Cargando…

Artificial exosomes for translational nanomedicine

Exosomes are lipid bilayer membrane vesicles and are emerging as competent nanocarriers for drug delivery. The clinical translation of exosomes faces many challenges such as massive production, standard isolation, drug loading, stability and quality control. In recent years, artificial exosomes are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yong-Jiang, Wu, Jun-Yong, Liu, Jihua, Xu, Wenjie, Qiu, Xiaohan, Huang, Si, Hu, Xiong-Bin, Xiang, Da-Xiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359033/ https://www.ncbi.nlm.nih.gov/pubmed/34384440 http://dx.doi.org/10.1186/s12951-021-00986-2

Ejemplares similares

From blood to brain: blood cell-based biomimetic drug delivery systems
por: Li, Yong-Jiang, et al.
Publicado: (2021)

Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona
por: Wu, Jun-Yong, et al.
Publicado: (2021)

Exosome: A New Player in Translational Nanomedicine
por: Aheget, Houssam, et al.
Publicado: (2020)

Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy
por: Li, Yongjiang, et al.
Publicado: (2022)

Polymalic acid for translational nanomedicine
por: Huang, Xing, et al.
Publicado: (2022)

Preservation of small extracellular vesicles for functional analysis and therapeutic applications: a comparative evaluation of storage conditions
por: Wu, Jun-Yong, et al.
Publicado: (2021)

Tango of dual nanoparticles: Interplays between exosomes and nanomedicine
por: Wang, Yabin, et al.
Publicado: (2021)

Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform
por: Xu, Xiao, et al.
Publicado: (2023)

Challenges in nanomedicine clinical translation
por: Metselaar, Josbert M., et al.
Publicado: (2020)

Bionanotechnology and Nanomedicine
por: Chase, P. Bryant, et al.
Publicado: (2012)

The Role of Optical Imaging in Translational Nanomedicine
por: Hesemans, Evelien, et al.
Publicado: (2022)

Promoting the bench-to-bedside translation of nanomedicines
por: Zhang, Ning
Publicado: (2023)

Bioimaging guided pharmaceutical evaluations of nanomedicines for clinical translations
por: Tuguntaev, Ruslan G., et al.
Publicado: (2022)

Exosomes in Gliomas: Biogenesis, Isolation, and Preliminary Applications in Nanomedicine
por: Romano, Eugenia, et al.
Publicado: (2020)

Current approaches of nanomedicines in the market and various stage of clinical translation
por: Shan, Xiaoting, et al.
Publicado: (2022)

Editorial: Translating nanomedicines for anti-cancer treatment
por: Siram, Karthik, et al.
Publicado: (2023)

Nanomedicine Ex Machina: Between Model-Informed Development and Artificial Intelligence
por: Villa Nova, Mônica, et al.
Publicado: (2022)

Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation
por: Burnouf, Thierry, et al.
Publicado: (2019)

Current hurdles to the translation of nanomedicines from bench to the clinic
por: Đorđević, Snežana, et al.
Publicado: (2021)

Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials
por: Xu, Manman, et al.
Publicado: (2023)

Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges
por: Cano, Amanda, et al.
Publicado: (2023)

Mesenchymal Stem Cell–Derived Exosomes: A Promising Biological Tool in Nanomedicine
por: Wei, Wumei, et al.
Publicado: (2021)

Advances in nanomedicines for lymphatic imaging and therapy
por: He, Pan, et al.
Publicado: (2023)

Biomedical applications of mRNA nanomedicine
por: Xiong, Qingqing, et al.
Publicado: (2018)

A scientometrics study of the nanomedicines assisted in respiratory diseases
por: Yang, Yi, et al.
Publicado: (2022)

Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease
por: Chen, Fengqian, et al.
Publicado: (2021)

Nanomedicines for Overcoming Cancer Drug Resistance
por: Hu, Tingting, et al.
Publicado: (2022)

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
por: Hua, Susan, et al.
Publicado: (2018)

Towards principled design of cancer nanomedicine to accelerate clinical translation
por: Souri, Mohammad, et al.
Publicado: (2022)

Virus-modified exosomes for targeted RNA delivery; A new approach in nanomedicine()
por: Koppers-Lalic, Danijela, et al.
Publicado: (2013)

Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
por: Xu, Yanyan, et al.
Publicado: (2022)

The Long and the Short of Current Nanomedicines for Treating Alzheimer's Disease
por: Gong, Baofeng, et al.
Publicado: (2023)

Current applications of graphene oxide in nanomedicine
por: Wu, Si-Ying, et al.
Publicado: (2015)

Editorial: Microenvironmental stimuli-responsive nanomedicine for biomedical application
por: Xia, Donglin, et al.
Publicado: (2023)

Nonviral delivery systems for antisense oligonucleotide therapeutics
por: Huang, Si, et al.
Publicado: (2022)

Phospholipid complex based nanoemulsion system for oral insulin delivery: preparation, in vitro, and in vivo evaluations
por: Hu, Xiong-Bin, et al.
Publicado: (2019)

Anticancer Nanotherapeutics in Clinical Trials: The Work behind Clinical Translation of Nanomedicine
por: Parodi, Alessandro, et al.
Publicado: (2022)

Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
por: Hu, Ping Ping, et al.
Publicado: (2022)

Comparison of Proangiogenic Effects of Adipose-Derived Stem Cells and Foreskin Fibroblast Exosomes on Artificial Dermis Prefabricated Flaps
por: Xiong, Jiachao, et al.
Publicado: (2020)

Heterocyclic Molecular Targeted Drugs and Nanomedicines for Cancer: Recent Advances and Challenges
por: Liu, Junxia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_48o2aoash55edb9hcooghhld0v